Tag: Aikido Pharma


Aikido Pharma Inc (NASDAQ: AIKI) Files Patent Submission for the Use of Ketamine to Treat Alzheimer’s Disease

Aikido Pharma Inc (NASDAQ: AIKI) announced that the company had filed a provisional patent application to use ketamine and peptides to handle Alzheimer’s disease. The company beforehand protected and announced patent rights for the use of peptides as a drug distribution scheme. This patent request seeks patent defense for the […]